SuperGen to Present at Noble Financial Capital Markets Equity Conference on May 17th
10 Mayo 2011 - 5:00AM
Business Wire
SuperGen, Inc. (NASDAQ:SUPG), a pharmaceutical company dedicated
to the discovery and development of novel cancer therapies, today
announced that Michael V. McCullar, Ph.D., senior vice president,
strategy and discovery operations, will present at Noble Financial
Capital Markets’ Seventh Annual Equity Conference on Tuesday, May
17th in Florida.
SuperGen's presentation will begin at 10:30 a.m. ET. A live
audio and high-definition video webcast of the presentation will be
available in the Investor Events section of the Company's website
at www.supergen.com. SuperGen recommends registering at least ten
minutes before the presentation to download the free presentation
viewer program. The webcast will be archived for 90 days.
About SuperGen
SuperGen is a pharmaceutical company dedicated to discovery and
development of novel cancer therapeutics in epigenetic and cell
signaling modulation. The Company develops products through
biochemical and clinical proof of concept to partner for further
development and commercialization. On April 6, 2011, SuperGen
entered into a definitive merger agreement to acquire Astex
Therapeutics Limited, a UK based biotechnology company. The
transaction is subject to customary regulatory, legal and
shareholder approvals. For more information about SuperGen, please
visit http://www.supergen.com.
Supergen, Inc. (MM) (NASDAQ:SUPG)
Gráfica de Acción Histórica
De May 2024 a Jun 2024
Supergen, Inc. (MM) (NASDAQ:SUPG)
Gráfica de Acción Histórica
De Jun 2023 a Jun 2024
Real-Time news about Supergen, Inc. (MM) (NASDAQ): 0 recent articles
Más de SuperGen, Inc. Artículos de Noticias